Fu; Yang-Xin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fu; Yang-Xin.The latest application filed is for "interleukin 12 fusion proteins, and compositions and therapeutic methods thereof".

Company Profile

2.12.21

Fu; Yang-Xin - Dallas TX
Fu; Yang-xin - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sting activating nanovaccine for immunotherapy Grant 11,376,324 - Gao , et al. July 5, 2	2022-07-05
Tumor-selective Combination Therapy App 20220160703 - FU; Yang-Xin ; et al.	2022-05-26
Interleukin 12 Fusion Proteins, And Compositions And Therapeutic Methods Thereof App 20220162280 - Fu; Yang-Xin ; et al.	2022-05-26
SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY App 20210290652 - Shay; Jerry ; et al.	2021-09-23
Interferon Prodrug For The Treatment Of Cancer App 20200123227 - FU; Yang-Xin ; et al.	2020-04-23
Anti-tumor therapy Grant 10,421,971 - Deng , et al. Sept	2019-09-24
Sting Activating Nanovaccine For Immunotherapy App 20190060446 - GAO; Jinming ; et al.	2019-02-28
Methods for cancer therapy using mutant light molecules with increased affinity to receptors Grant 10,167,328 - Fu J	2019-01-01
Methods And Compositions For Cancer Therapy Using Mutant Light Molecules With Increased Affinity To Receptors App 20170137484 - Fu; Yang-Xin	2017-05-18
Antibody-light fusion products for cancer therapeutics Grant 9,623,116 - Fu April 18, 2	2017-04-18
Anti-tumor Therapy App 20160333355 - Deng; Liufu ; et al.	2016-11-17
Compositions for cancer therapy using mutant light molecules with increased affinity to receptors Grant 9,493,532 - Fu November 15, 2	2016-11-15
Increased T-cell Tumor Infiltration And Eradication Of Metastases By Mutant Light App 20160317631 - Fu; Yang-Xin	2016-11-03
Methods And Compositions To Reduce Liver Damage Associated With Conditions Or Therapies That Affect The Immune System App 20160250327 - Fu; Yang-Xin	2016-09-01
Increased T-cell tumor infiltration and eradication of metastases by mutant light Grant 9,272,025 - Fu March 1, 2	2016-03-01
Antibody-light Fusion Products For Cancer Therapeutics App 20150283260 - Fu; Yang-Xin	2015-10-08
Antibody-light fusion products for cancer therapeutics Grant 9,061,073 - Fu June 23, 2	2015-06-23
Methods Of Treating Obesity App 20150157692 - Fu; Yang-Xin	2015-06-11
Methods And Compositions For Cancer Therapy Using Mutant Light Molecules With Increased Affinity To Receptors App 20150056219 - Fu; Yang-Xin	2015-02-26
Antibody-light Fusion Products For Cancer Therapeutics App 20120328558 - Fu; Yang-Xin	2012-12-27
Antibody-light fusion products for cancer therapeutics Grant 8,263,081 - Fu September 11, 2	2012-09-11
Methods And Compositions To Reduce Liver Damage Associated With Conditions Or Therapies That Affect The Immune System App 20120014947 - Fu; Yang-Xin	2012-01-19
Antibody-light Fusion Products For Cancer Therapeutics App 20110020340 - Fu; Yang-Xin	2011-01-27
Increased T-cell Tumor Infiltration And Eradication Of Metastases By Mutant Light App 20110014152 - Fu; Yang-Xin	2011-01-20
Increased T-cell tumor infiltration and eradication of metastases by mutant light Grant 7,811,983 - Fu October 12, 2	2010-10-12
Increased T-cell tumor infiltration by mutant LIGHT Grant 7,807,784 - Fu October 5, 2	2010-10-05
Increased T-cell tumor infiltration and eradication of metastases by mutant LIGHT App 20090092640 - Fu; Yang-Xin	2009-04-09
Combination Therapy For Treating Cancer App 20090093429 - Fu; Yang-Xin ; et al.	2009-04-09
Treatment And Prophylaxis With 4-1BB-Binding Agents App 20090068193 - Chen; Lieping ; et al.	2009-03-12
Increased T-cell tumor infiltration by mutant light App 20050025754 - Fu, Yang-Xin	2005-02-03
Treatment and prophylaxis with 4-1BB-binding agents App 20040109847 - Chen, Lieping ; et al.	2004-06-10

Company Registrations

NCAGE Code	4ENM7	FU YANG-XIN
CAGE Code	4ENM7	FU, YANG-XIN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.